Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Cancer
Cancer
Page 25 of 26
Features
These are the Fortune 500’s fastest-growing pharma companies
By
Laura Lorenzetti
June 20, 2015
Features
Cancer drug spending hit $100 billion in 2014. Here’s why it’ll soon be much higher
By
Laura Lorenzetti
May 8, 2015
Tech
How one company is using artificial intelligence to develop a cure for cancer
By
Cyrus Sanati
April 16, 2015
Features
The Roundup problem: Why it’s so hard to pinpoint what causes cancer
By
Laura Lorenzetti
April 15, 2015
Tech
An audacious attempt to cure pancreatic cancer
By
Cyrus Sanati
April 7, 2015
International
Takeda’s ready to shell out $2.2 billion to settle Actos drug cases
By
Laura Lorenzetti
April 1, 2015
Finance
Forget the Roundup cancer report, Monsanto’s worried about a stronger U.S. dollar
By
Laura Lorenzetti
April 1, 2015
Features
GoDaddy goes public and RadioShack lives on — 5 things to know today
By
Laura Lorenzetti
April 1, 2015
Features
Ken Burns talks to Fortune about his latest project: a history of cancer
By
Laura Lorenzetti
March 29, 2015
Features
Merck halts study in light of melanoma drug’s success
By
Laura Lorenzetti
March 24, 2015
MPW
Meet ‘The Bachelor’ contestant with her own organic cosmetics company
By
Deena Shanker
March 16, 2015
Features
FDA approves the first biosimilar for the U.S. market
By
Laura Lorenzetti
March 6, 2015
Finance
AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By
Reuters
March 5, 2015
Features
In speed mode, FDA approves Pfizer’s big new drug early
By
Jen Wieczner
February 4, 2015
Features
The U.S. has a drug shortage — and people are dying
By
Mark Koba
January 6, 2015
Most Popular
Economy
Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30...
By
Eleanor Pringle
Economy
‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
By
Jim Edwards
Newsletters
The oil CEO who stood up to Trump is a follower of the disciplined 'Exxon way' and has a history of blunt statements
By
Jordan Blum